Sun Pharma Buys Out Remainder Of Caraco
The deal, valuing Caraco's stock at $5.25 a share, was struck Monday, Caraco announced.
Sun Pharma and subsidiary Sun Pharma Global Inc. had previously proposed a transaction to go private, by which the companies or one or more of their affiliates would acquire all of the outstanding shares of Caraco common stock...
Already a subscriber? Click here to login